Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP warns Beveragette not to overstate efficacy claims

This article was originally published in The Tan Sheet

Executive Summary

Beveragette Ventures can keep marketing claims that its GEM Keep It Cool Menopause Relief Drink reduces symptoms of menopause, but should drop modifiers like "dramatically" and "significantly," the Electronic Retailing Self-Regulation Program says in a report released Feb. 11. The industry watchdog explained the modifiers and testimonials suggesting consumers would receive "immediate results" overstated "the breadth of evidence" the firm submitted. However, the firm provided sufficient data to support claims that its supplement, made mostly of natural extract from black cohosh root, could help alleviate menopause-related hot flashes, night sweats and irritability. Beveragette said it would comply with the recommendations

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103796

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel